The store will not work correctly when cookies are disabled.
2-(3-(4-methoxyphenyl)-5-methyl-1-phenyl-1H-pyrazol-4-yl)-5-phenyl-1,3,4-oxadiazole
ID: ALA3099512
PubChem CID: 72947071
Max Phase: Preclinical
Molecular Formula: C25H20N4O2
Molecular Weight: 408.46
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(-c2nn(-c3ccccc3)c(C)c2-c2nnc(-c3ccccc3)o2)cc1
Standard InChI: InChI=1S/C25H20N4O2/c1-17-22(25-27-26-24(31-25)19-9-5-3-6-10-19)23(18-13-15-21(30-2)16-14-18)28-29(17)20-11-7-4-8-12-20/h3-16H,1-2H3
Standard InChI Key: CIPUIRAYBBDUGC-UHFFFAOYSA-N
Molfile:
RDKit 2D
31 35 0 0 0 0 0 0 0 0999 V2000
12.1915 -10.6152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3743 -10.6110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1178 -11.3870 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.7765 -11.8707 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4400 -11.3937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7717 -12.6849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0603 -13.0893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0559 -13.9057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7620 -14.3187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4742 -13.9093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4751 -13.0942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2159 -11.6501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8995 -9.9495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2373 -9.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7611 -8.5411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9470 -8.6220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6115 -9.3718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0898 -10.0318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6746 -9.9593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4918 -9.9634 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.7483 -9.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0896 -8.7038 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4261 -9.1808 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.5270 -8.9396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1314 -9.4912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9092 -9.2432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0838 -8.4440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4744 -7.8932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6989 -8.1441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4692 -7.9591 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.8044 -7.2138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 1 2 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
4 6 1 0
5 12 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
2 13 1 0
19 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 19 2 0
1 19 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
21 24 1 0
16 30 1 0
30 31 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 408.46 | Molecular Weight (Monoisotopic): 408.1586 | AlogP: 5.57 | #Rotatable Bonds: 5 |
Polar Surface Area: 65.97 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 1.36 | CX LogP: 5.17 | CX LogD: 5.17 |
Aromatic Rings: 5 | Heavy Atoms: 31 | QED Weighted: 0.38 | Np Likeness Score: -1.15 |
References
1. Ningaiah S, Bhadraiah UK, Doddaramappa SD, Keshavamurthy S, Javarasetty C.. (2014) Novel pyrazole integrated 1,3,4-oxadiazoles: synthesis, characterization and antimicrobial evaluation., 24 (1): [PMID:24316123] [10.1016/j.bmcl.2013.11.029] |